retatrutide lawsuit Reports claim that a single well-connected patient received early access to Eli Lilly's experimental weight-loss drug, Retatrutide, through the FDA's compassionate use program before approval. The patient was reportedly 79 years old This weight-loss drug hasn't been

However, the effects of growing generic competition are already being seen as sales of NovoMix dropped from $1.37 billion in 2021 to $1.118 billion in 2022

The interaction between GLP-1 medications and oral hormonal treatments can affect absorption and efficacy

10.2337/dc13-0663 118

But I wouldnt be concerned about GLP-1 medicines causing more than expected losses in bone densities with the amount of weight lost, he told Healthline

Meta-analyses further confirm these findings, showing a robust reduction in the composite outcome of HF hospitalization and cardiovascular death (HR 0.80

Tirzepatide is a dual agonist that activates GIP and GLP-1 receptors